Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Director/PDMR Shareholding

7 Dec 2006 07:02

ReNeuron Group plc07 December 2006 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer 2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or ReNeuron Group plc (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) Notification under (ii) above. 3. Name of person discharging managerial 4. State whether notification relates to a person responsibilities/director connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person Trevor Jones, Director N/A 5. Indicate whether the notification is in respect 6. Description of shares (including class), of a holding of the person referred to in 3 or 4 debentures or derivatives or financial above or in respect of a non-beneficial interest instruments relating to shares 1 Beneficial Interest Ordinary Shares 7. Name of registered shareholders(s) and, if more 8. State the nature of the transaction than one, the number of shares held by each of them Purchase Trevor Jones 9. Number of shares, debentures or financial 10. Percentage of issued class acquired (treasury instruments relating to shares acquired shares of that class should not be taken into account when calculating percentage) 25,700 shares 0.03% 11. Number of shares, debentures or financial 12. Percentage of issued class disposed (treasury instruments relating to shares disposed shares of that class should not be taken into account when calculating percentage) N/A N/A 13. Price per share or value of transaction 14. Date and place of transaction 19.5p per share 6 December 2006, England 15. Total holding following notification and total 16. Date issuer informed of transaction percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 6 December 2006 83,200 shares If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17. Date of grant 18. Period during which or date on which it can be exercised 19. Total amount paid (if any) for grant of the 20. Description of shares or debentures involved option (class and number) 21. Exercise price (if fixed at time of grant) or 22. Total number of shares or debentures over which indication that price is to be fixed at the time options held following notification of exercise 23. Any additional information 24. Name of contact and telephone number for queries Name and signature of duly authorised officer of issuer responsible for making notification __________________________________________________________ Date of notification _____________________________________ This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Dec 20067:00 amRNSFiles IND Application
6th Dec 20067:00 amRNSInterim Results
30th Nov 20067:01 amRNSRe Agreement
20th Nov 20067:00 amRNSMarket Launch of ReNcell
15th Nov 20067:02 amRNSExercise of Warrants
9th Oct 20069:50 amRNSTo Present Data in October
21st Sep 200611:49 amRNSRe: Warrant Holder Meeting
21st Sep 200611:45 amRNSAGM Statement
19th Sep 20063:39 pmRNSIssue of Equity
4th Sep 20065:31 pmRNSDirector/PDMR Shareholding
4th Sep 20065:31 pmRNSDirector/PDMR Shareholding
4th Sep 20065:23 pmRNSDirector/PDMR Shareholding
4th Sep 20065:18 pmRNSDirector/PDMR Shareholding
30th Aug 200612:03 pmRNSHolding(s) in Company
30th Aug 200611:57 amRNSHolding(s) in Company
23rd Aug 20063:19 pmRNSAGM
23rd Aug 20067:01 amRNSRe: Clinical Investigator
29th Jun 20062:21 pmRNSHolding(s) in Company
29th Jun 20067:02 amRNSResearch Update
28th Jun 20067:01 amRNSRe Placing
28th Jun 20067:01 amRNSFinal Results
26th Jun 20063:27 pmRNSNotice of Results
5th Jun 20067:02 amRNSConference
11th May 20062:35 pmRNSHolding(s) in Company
26th Apr 20065:17 pmRNSDirector/PDMR Shareholding
26th Apr 20065:13 pmRNSDirector/PDMR Shareholding
26th Apr 20065:09 pmRNSDirector/PDMR Shareholding
26th Apr 20065:03 pmRNSDirector/PDMR Shareholding
26th Apr 20064:59 pmRNSDirector/PDMR Shareholding
18th Apr 20067:02 amRNSRe Agreement
18th Apr 20067:02 amRNSRe Agreement
10th Apr 20061:52 pmRNSHolding(s) in Company
5th Apr 20069:08 amRNSIntention to raise funds
4th Apr 20069:52 amRNSResearch Update
8th Mar 20067:32 amRNSResearch Update
7th Mar 20067:00 amRNSRe: BioSquare Conference
16th Feb 20067:01 amRNSResearch Update
7th Feb 20067:01 amRNSRe: Manufacturing Contract
6th Feb 20067:01 amRNSResearch Update
24th Jan 20067:00 amRNSRe US Patent Office
6th Dec 200510:03 amRNSRe Conference
2nd Dec 200511:19 amRNSRe: Government Support
30th Nov 20057:00 amRNSInterim Results
23rd Nov 20054:57 pmRNSNotice of Results
18th Nov 20057:00 amRNSResearch Update
25th Oct 20057:00 amRNSResearch Update
5th Oct 20059:59 amRNSHolding(s) in Company
22nd Sep 200510:31 amRNSResearch Update
20th Sep 20059:13 amRNSDirector/PDMR Shareholding
16th Sep 20051:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.